Madrigal Pharmaceuticals, Inc. MDGL Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s financing cash flow?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported financing cash flow of $2.33M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s financing cash flow changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s financing cash flow decreased by 73.0% year-over-year, from $8.64M to $2.33M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s financing cash flow has grown at a 10.6% compound annual growth rate (CAGR), from $171.24M to $255.98M.
- What does financing cash flow mean?
- The net amount of cash generated from or spent on financing activities like issuing stock or paying down debt.
- How do you interpret financing cash flow?
- Positive values indicate net capital inflows from investors or lenders, while negative values indicate capital returned to stakeholders or debt repayment.
- How does financing cash flow compare across companies?
- Highly variable based on the company's stage in the business lifecycle and capital structure strategy.